PROCEPT BioRobotics Corporation (PRCT) Tops Q3 EPS by 3c, provides guidance

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q3 EPS of ($0.38), $0.03 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $83.3 million versus the consensus estimate of $80.83 million.

GUIDANCE:

PROCEPT BioRobotics Corporation sees FY2025 revenue of $325.5 million, versus the consensus of $326.5 million.

PROCEPT BioRobotics Corporation sees FY2026 revenue of $410-430 million, versus the consensus of $427 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.

You May Also Be Interested In

• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• Boeing wins $121 million Navy contract for P-8A upgrades
• Japan's Katayama, Us Treasury's Bessent Hold Online Talks, Source Says - Reuters